Parmax Pharma Ltd
BSE: 540359
Shareholding Trends
Ownership split
Institutional detail
Q1 FY27
Corporate Events
Board Meeting
To consider and approve unaudited financial results for the …
BSE Filing ↗Board Meeting
The Annual General Meeting will be held to consider and adop…
BSE Filing ↗Board Meeting
The Thirty Second (32nd) Annual General Meeting (AGM) of Mem…
BSE Filing ↗Board Meeting
The Board of Directors approved the allotment of 31,37,586 f…
BSE Filing ↗Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗Board Meeting
The Extraordinary General Meeting (EGM) of the Company is sc…
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve fund …
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve the a…
BSE Filing ↗Board Meeting
Reschedule of Board Meeting, Approve and consider unaudited …
BSE Filing ↗Board Meeting
Consider and approve un-audited standalone financial results
BSE Filing ↗